EDAP TMS SA (EDAP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EDAP TMS SA (EDAP) has a cash flow conversion efficiency ratio of -0.294x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.97 Million) by net assets ($10.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EDAP TMS SA (EDAP) defensive interval to measure how many days the company can operate on defensive assets alone.
EDAP TMS SA - Cash Flow Conversion Efficiency Trend (1997–2025)
This chart illustrates how EDAP TMS SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
EDAP TMS SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EDAP TMS SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Condor Energies Inc.
TO:CDR
|
0.082x |
|
Lippo Cikarang Tbk
JK:LPCK
|
-0.008x |
|
Meridian Holdings Inc
NASDAQ:MRDN
|
0.102x |
|
Unic Technology
TWO:5452
|
0.064x |
|
Cartesian Growth Corporation II Class A Ordinary Shares
NASDAQ:RENE
|
-0.007x |
|
Nnit AS
CO:NNIT
|
-0.076x |
|
Fu Yu Property Co Ltd
TWO:4907
|
0.079x |
|
Cheil Electric Wiring Devices Co. Ltd.
KQ:199820
|
0.054x |
Annual Cash Flow Conversion Efficiency for EDAP TMS SA (1997–2025)
The table below shows the annual cash flow conversion efficiency of EDAP TMS SA from 1997 to 2025. For the full company profile with market capitalisation and key ratios, see EDAP TMS SA market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $19.41 Million | $-16.41 Million | -0.845x | -154.47% |
| 2024-12-31 | $40.90 Million | $-13.58 Million | -0.332x | -28.82% |
| 2023-12-31 | $56.92 Million | $-14.68 Million | -0.258x | -510.79% |
| 2022-12-31 | $71.63 Million | $-3.02 Million | -0.042x | -147.54% |
| 2021-12-31 | $50.05 Million | $4.45 Million | 0.089x | +3.42% |
| 2020-12-31 | $26.25 Million | $2.25 Million | 0.086x | -38.18% |
| 2019-12-31 | $27.36 Million | $3.80 Million | 0.139x | +1881.34% |
| 2018-12-31 | $24.96 Million | $175.00K | 0.007x | +105.77% |
| 2017-12-31 | $25.16 Million | $-3.06 Million | -0.122x | -365.69% |
| 2016-12-31 | $24.45 Million | $1.12 Million | 0.046x | -50.64% |
| 2015-12-31 | $14.43 Million | $1.34 Million | 0.093x | +238.45% |
| 2014-12-31 | $15.14 Million | $-1.01 Million | -0.067x | +75.08% |
| 2013-12-31 | $9.28 Million | $-2.50 Million | -0.269x | -1253.83% |
| 2012-12-31 | $8.16 Million | $-162.00K | -0.020x | +76.53% |
| 2011-12-31 | $8.71 Million | $-737.00K | -0.085x | +80.28% |
| 2010-12-31 | $8.90 Million | $-3.82 Million | -0.429x | -47.28% |
| 2009-12-31 | $12.58 Million | $-3.66 Million | -0.291x | -9.02% |
| 2008-12-31 | $17.19 Million | $-4.59 Million | -0.267x | -41.95% |
| 2007-12-31 | $14.52 Million | $-2.73 Million | -0.188x | -91.08% |
| 2006-12-31 | $19.30 Million | $-1.90 Million | -0.099x | -500.94% |
| 2005-12-31 | $17.36 Million | $-284.53K | -0.016x | +74.02% |
| 2004-12-31 | $17.95 Million | $-1.13 Million | -0.063x | +67.23% |
| 2003-12-31 | $18.93 Million | $-3.64 Million | -0.192x | +31.41% |
| 2002-12-31 | $28.40 Million | $-7.97 Million | -0.281x | -221.04% |
| 2001-12-31 | $38.98 Million | $-3.41 Million | -0.087x | -10295.04% |
| 2000-12-31 | $34.78 Million | $29.81K | 0.001x | +100.52% |
| 1999-12-31 | $15.47 Million | $-2.54 Million | -0.164x | +36.19% |
| 1998-12-31 | $24.90 Million | $-6.39 Million | -0.257x | -2288.70% |
| 1997-12-31 | $33.82 Million | $-363.64K | -0.011x | -- |
About EDAP TMS SA
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment de… Read more